Nerlynx sales
Puma Biotechnology Reports Third Quarter 2025 Financial Results
Puma Biotechnology; Q3 2025; financial results; EPS beat; revenue decline; Nerlynx sales; net income; oncology; clinical trials; revenue guidance
Actionable Insights Powered by AI
Puma Biotechnology; Q3 2025; financial results; EPS beat; revenue decline; Nerlynx sales; net income; oncology; clinical trials; revenue guidance